Lin Zhi
About Lin Zhi
Lin Zhi serves as the Vice President of Chemistry & Pharmaceutical Sciences at Ligand Pharmaceuticals, a position he has held since 1992. He holds a Ph.D. in Organic Chemistry from Emory University and has extensive academic credentials from Stanford University and Peking University.
Work at Ligand Pharmaceuticals
Lin Zhi has served as Vice President of Chemistry & Pharmaceutical Sciences at Ligand Pharmaceuticals since 1992. In this role, Zhi oversees various aspects of chemistry and pharmaceutical development, contributing to the company's research and development initiatives. With over three decades of experience at Ligand, Zhi plays a crucial role in advancing the company's scientific goals and product pipeline.
Education and Expertise
Lin Zhi's educational background includes a Ph.D. in Organic Chemistry from Emory University, completed between 1986 and 1990. Prior to this, Zhi earned a B.S. and M.S. in Chemistry from Peking University, studying from 1978 to 1984. Zhi furthered expertise in the field through a Postdoctoral fellowship in Organic Chemistry at Stanford University from 1991 to 1992. This extensive academic training provides a strong foundation for Zhi's work in pharmaceutical sciences.
Background
Lin Zhi's academic journey began at Peking University, where Zhi studied Chemistry for six years, culminating in both a B.S. and M.S. degree. Following this, Zhi pursued a Ph.D. in Organic Chemistry at Emory University, which was completed in four years. Zhi's postdoctoral work at Stanford University further honed skills in Organic Chemistry, contributing to a robust background in the field.
Professional Experience
With over 32 years of experience at Ligand Pharmaceuticals, Lin Zhi has developed a deep understanding of the pharmaceutical industry. Zhi's role as Vice President encompasses leadership in chemistry and pharmaceutical sciences, focusing on the development of innovative solutions and products. This extensive tenure reflects a commitment to advancing the company's objectives and enhancing its scientific capabilities.